ACTIGALL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Actigall, and when can generic versions of Actigall launch?
Actigall is a drug marketed by Teva Branded Pharm and is included in one NDA.
The generic ingredient in ACTIGALL is ursodiol. There are eight drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the ursodiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Actigall
A generic version of ACTIGALL was approved as ursodiol by EPIC PHARMA on March 14th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACTIGALL?
- What are the global sales for ACTIGALL?
- What is Average Wholesale Price for ACTIGALL?
Summary for ACTIGALL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 93 |
Clinical Trials: | 6 |
Patent Applications: | 4,412 |
Drug Prices: | Drug price information for ACTIGALL |
What excipients (inactive ingredients) are in ACTIGALL? | ACTIGALL excipients list |
DailyMed Link: | ACTIGALL at DailyMed |
Recent Clinical Trials for ACTIGALL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Texas Health Science Center at San Antonio | Phase 2 |
Texas Children's Hospital | Phase 1 |
University of Tennessee | Phase 1 |
US Patents and Regulatory Information for ACTIGALL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Branded Pharm | ACTIGALL | ursodiol | CAPSULE;ORAL | 019594-001 | Dec 31, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Branded Pharm | ACTIGALL | ursodiol | CAPSULE;ORAL | 019594-002 | Dec 31, 1987 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |